Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2000
10/10/2000US6130323 Capable of substituting for nucleotide in an oligonucleotide; for incorporating labels but still maintaining correct spacings and hybridization efficiency
10/10/2000US6130322 Nucleotide sequence comprising breast cancer gene-1; for the detection of mutations which amplify genetic sensitivity to breast or ovarian cancer; for the diagnosis and treatment of hereditary breast and ovarian cancer; for gene therapy
10/10/2000US6130314 Peptide which is immunoreactive to antibodies to lymphadenopathy virus and human t-cell lymphotropic virus; for detection of exposure to virus and screening blood products
10/10/2000US6130313 Rapidly degrading GFP-fusion proteins
10/10/2000US6130204 Peptides
10/10/2000US6130073 Coupled amplification and ligation method
10/10/2000US6130071 Vascular endothelial growth factor C (VEGF-C) ΔCys156 protein and gene, and uses thereof
10/10/2000US6130067 Human EDG3sb gene
10/10/2000US6130064 Amino acid sequence encoded by polynucleotide from survival motor neuron gene; diagnosis, treatment, and prevention of nervous system, reproductive, and cell proliferative disorders; antiproliferative/anticarcinogenic agents
10/10/2000US6130059 Recombinant polynucleotide of cytotoxin having defined nucleotide sequence
10/10/2000US6130057 Method for differentiating microorganisms in a sample
10/10/2000US6130055 Method for measuring the concentration or the activity of protease inhibitor
10/10/2000US6130054 Test strip for creatine kinase activity measurement
10/10/2000US6130053 Method for selecting compounds for inhibition of neoplastic lesions
10/10/2000US6130052 Leukemia associated genes
10/10/2000US6130048 Determining level of cystatin c in cerebrospinal fluid and comparing to normal levels; increase indicates disease
10/10/2000US6130047 Detection of nucleic acids by fluorescence quenching
10/10/2000US6130044 Surfaces for biological reactions, process for preparing them and process for their use
10/10/2000US6130043 Contacting sample with one prostate-specific polynucleotide or complement and detecting presence of target polynucleotide
10/10/2000US6130042 Treating patient sample to detect a genotype homozygous for allele 1 at the +3953 polymorphic site of interleukin-1b gene which is a high risk indicator of generalized early onset periodontal disease
10/10/2000US6130041 Allele of polymorphic region of gene coding for receptor which binds low density and high density lipoproteins; screening for abnormal lipid metabolism, cardiovascular disease, atherosclerosis, gallstone formation, or obesity
10/10/2000US6130039 Nucleotide and amino acid sequences; for recombinant production of protein; antibodies; primers; probes; diagnosis of cancer; anticarcinogenic agents
10/10/2000US6130038 Contacting sample with oligonucleotide primer having one or more ribonucleotides modified to contain a 2'-o-methyl substitution, incubating under conditions for amplification; increased hybridization affinity for rna
10/10/2000US6130037 Biosensor device and method
10/10/2000US6130036 Methods and compositions for screening for anti-AIDS drugs
10/10/2000US6130035 Use of orotidine monophosphate decarboxylase inhibition in a method for cancer screening
10/10/2000US6129926 Flash flow processing of thermoplastic polymers and products made therefrom
10/10/2000US6129823 Low volume electrochemical sensor
10/10/2000CA2205804C A high-throughput screening assay for inhibitors of nucleic acid polymerases
10/10/2000CA2196797C In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene
10/10/2000CA2196790C 17q-linked breast and ovarian cancer susceptibility gene
10/10/2000CA2080231C 2'-o-alkylnucleotides as well as polymers which contain such nucleotides
10/10/2000CA2062969C Recombinantly produced human membrane cofactor protein (mcp)
10/10/2000CA2021581C Improved stable coagulation controls
10/09/2000CA2304876A1 Methods for classifying samples and ascertaining previously unknown classes
10/09/2000CA2302898A1 Nucleotide sequence for detection and characterization of the hiv-1 field isolates participating in the recombination processes directed by the chi sequence
10/08/2000CA2268695A1 Apparatus and method for analyzing information in arrays of information sites
10/08/2000CA2266760A1 Methylation of arginine and related amino acids
10/06/2000CA2304424A1 Assays for the determination of pesticidal damage, resistance, and pesticide mode of action
10/06/2000CA2302828A1 Sequence-determined dna fragments and corresponding polypeptides encoded thereby
10/05/2000WO2000058730A1 Method and device for detecting analytes in fluids
10/05/2000WO2000058726A1 Method for quantitating leukocyte count in whole blood sample
10/05/2000WO2000058524A2 Typing of human enteroviruses
10/05/2000WO2000058522A1 Single nucleotide polymorphic discrimination by electronic dot blot assay on semiconductor microchips
10/05/2000WO2000058521A2 Methods for the identification of reporter and target molecules using comprehensive gene expression profiles
10/05/2000WO2000058520A1 Methods for identifying pathway-specific reporters and target genes, and uses thereof
10/05/2000WO2000058519A2 Charaterization of single nucleotide polymorphisms in coding regions of human genes
10/05/2000WO2000058518A2 Genetic marker test for lupus
10/05/2000WO2000058517A1 Exonuclease-mediated nucleic acid reassembly in directed evolution
10/05/2000WO2000058516A2 Universal arrays
10/05/2000WO2000058515A1 Mutations associated with iron disorders
10/05/2000WO2000058514A2 Methods for improving sensitivity and specificity of screening assays
10/05/2000WO2000058513A1 49 human secreted proteins
10/05/2000WO2000058511A1 Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3)
10/05/2000WO2000058510A2 Schizophrenia associated genes, proteins and biallelic markers
10/05/2000WO2000058509A2 Prostate cancer associated human fibronectin gene and biallelic markers
10/05/2000WO2000058508A2 Biallelic markers related to genes involved in drug metabolism
10/05/2000WO2000058507A1 Polynucleotide sequencing
10/05/2000WO2000058506A2 Susceptibility to psoriasis
10/05/2000WO2000058505A1 Detection of nucleic acid amplified products
10/05/2000WO2000058504A1 High throughput screening method for determining enantioselectivity
10/05/2000WO2000058503A2 Improved method for detecting micro-organisms
10/05/2000WO2000058502A2 Use of collagenase 3 for detecting destructive diseases of the joints
10/05/2000WO2000058496A1 50 human secreted proteins
10/05/2000WO2000058495A1 45 human secreted proteins
10/05/2000WO2000058494A1 50 human secreted proteins
10/05/2000WO2000058485A1 Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus
10/05/2000WO2000058483A2 Protozoan expression system
10/05/2000WO2000058477A1 Method for detecting mutation in hepatitis b virus and detection kit
10/05/2000WO2000058475A2 Streptococcus pneumoniae antigens
10/05/2000WO2000058474A1 Compositions and methods for the modification of gene expression
10/05/2000WO2000058473A2 Nucleic acids including open reading frames encoding polypeptides; 'orfx'
10/05/2000WO2000058472A2 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same
10/05/2000WO2000058470A1 Prostate-specific gene, pcgem1, and methods of using pcgem1 to detect, treat, and prevent prostate cancer
10/05/2000WO2000058469A1 48 human secreted proteins
10/05/2000WO2000058468A2 47 human secreted proteins
10/05/2000WO2000058467A1 50 human secreted proteins
10/05/2000WO2000058460A2 Casb619 involved in colon cancers
10/05/2000WO2000058457A2 Essential genes of yeast as targets for antifungal agents, herbicides, insecticides and anti-proliferation drugs
10/05/2000WO2000058455A2 Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection
10/05/2000WO2000058446A1 HUMAN PROTEIN KINASE Bη POLYPEPTIDES AND A METHOD FOR DISRUPTING PROTEIN KINASE Bη IN A NON-HUMAN
10/05/2000WO2000058440A1 Diagnosis of whipple disease
10/05/2000WO2000058439A2 Screening methods for compounds that inhibit or stimulate helicase enzyme activity
10/05/2000WO2000058406A1 4,7-dichlororhodamine dyes useful as molecular probes
10/05/2000WO2000058363A1 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
10/05/2000WO2000058358A1 49 human secreted proteins
10/05/2000WO2000058357A1 50 human secreted proteins
10/05/2000WO2000058356A1 50 human secreted proteins
10/05/2000WO2000058355A1 50 human secreted proteins
10/05/2000WO2000058352A2 Barley gene for thioredoxin and nadp-thioredoxin reductase
10/05/2000WO2000058350A1 49 human secreted proteins
10/05/2000WO2000058340A2 50 human secreted proteins
10/05/2000WO2000058339A2 50 human secreted proteins
10/05/2000WO2000058335A1 47 human secreted proteins
10/05/2000WO2000058334A1 50 human secreted proteins
10/05/2000WO2000058330A2 Pseudo-cyclic oligonucleobases
10/05/2000WO2000057915A1 Method of affecting cholesterol catabolism using nuclear bile acid receptor
10/05/2000WO2000057908A2 Attenuated dengue-1 virus vaccine
10/05/2000WO2000057905A1 Recombinant neospora antigens and their uses
10/05/2000WO2000057903A2 48 human secreted proteins
1 ... 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 ... 3003